February 12, 2016 |
TransCelerate BioPharma Inc., a King of Prussia-based nonprofit organization that aims to find quicker and more efficient ways of producing new medicines, said Wednesday it was launching a subsidiary, BioCelerate, to improve efficiencies in preclinical research. Six pharmaceutical companies will be founding members of BioCelerate. The first initiative will be sharing toxicity data in preclinical studies, according to TransCelerate CEO Dalvir Gill. The six member drugmakers are: Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly & Co., GlaxoSmithKline, Novo Nordisk, and Shionogi & Co. firstname.lastname@example.org 215-854-2831 @LoydLinda
January 14, 2016 |
Tmunity Therapeutics Inc., a Philadelphia company founded last year to build on research at the University of Pennsylvania's Center for Cellular Immunotherapies, said it received a $10 million investment from Penn Medicine and Lilly Asia Ventures, an affiliate of drugmaker Eli Lilly & Co. Gene therapy pioneer Carl June, who has led Penn's immunotherapy trials for more than two decades, cofounded Tmunity, which is working on therapies that enable...
January 13, 2016
In the Region Penn Medicine funds drug firm Tmunity Therapeutics Inc. , a Philadelphia company founded last year to build on research at the University of Pennsylvania's Center for Cellular Immunotherapies, said it received a $10 million investment from Penn Medicine and Lilly Asia Ventures , an affiliate of drugmaker Eli Lilly & Co . Gene therapy pioneer Carl June, who has led Penn's immunotherapy trials for more than two decades, cofounded...
January 4, 2016 |
Injectable insulin, which keeps some diabetics alive and keeps others out of serious health crises, has soared in price in the last few years. "It is out of control," said Carol Hammond, 72, a diabetic who lives in North Philadelphia and survives on Social Security. "My rent isn't too bad, but after paying for insulin, I don't have much left. " Hammond said she skips buying or taking doses because her Medicare and Medicare Advantage health- insurance plans don't always cover the cost of her insulin at the pharmacy counter.
June 4, 2015 |
The University City Science Center plans to more than double its size over 10 years as it seeks to lure higher-profile biomedical and technology firms to the West Philadelphia business incubation and research complex. The Science Center and its development partner on the expansion, Wexford Science & Technology, will pool their landholdings in the area to build more than four million square feet of offices, laboratories, homes, retail shops, and parking structures, the Science Center said Tuesday.
April 24, 2014 |
In a multibillion-dollar deal, drugmakers GlaxoSmithKline and Novartis said Tuesday that they would trade parts of their companies and form a joint venture with a third part. GSK, based in London and with several facilities in the Philadelphia region, will sell its current cancer drugs to Swiss-based Novartis for $16 billion. Novartis will sell all but one of its vaccines to GSK for about $7.1 billion. The companies formed a joint venture to sell over-the-counter medicine, with GSK taking a 63.5 percent stake.
October 21, 2013 |
Shares of ViroPharma Inc., a drugmaker with headquarters in Exton that specializes in medicines for rare diseases, soared after recent reports that the European pharmaceutical companies Sanofi and Shire P.L.C. might be interested in buying the company. ViroPharma stock closed Sept. 17 at a 13-year high of $40.78. Since then, some analysts say, it has become unclear whether the buyout will happen. "A deal would make sense, but it's still speculative," said Akiva Felt, biotechnology analyst with Oppenheimer & Co. in San Francisco.
July 11, 2013 |
Finding a cure for Alzheimer's disease remains a dream for patients suffering from the debilitating brain condition, family members struggling to help them, and pharmaceutical companies hoping to make billions of dollars treating them. But there is no consensus on even the best direction of research, and that uncertainty has affected a Philadelphia subsidiary of Eli Lilly & Co., Avid Radiopharmaceuticals. The Centers for Medicare and Medicaid (CMS) said last week that it probably would not pay for as many of the diagnostic tests Lilly hoped it would when the drug giant bought Avid in 2010.
July 1, 2013
Daniel M. Skovronsky, M.D., Ph.D . Age: 39. Title: President, CEO, Avid Radiopharmaceuticals Inc. Number of Employees: About 100. Tenure: Founded the molecular imaging agent company in December 2004. Financials: In 2010, Eli Lilly & Co. bought Avid for up to $800 million if benchmarks were met. Diagnosing Alzheimer's: More than 100 years ago, Dr. Alois Alzheimer [the discoverer of Alzheimer's disease] had a patient with dementia. After she died, he looked at her brain under the microscope and discovered it was full of these things called amyloid plaques.
May 8, 2013 |
The drugmaker Pfizer Inc. said Monday that it would begin selling its erectile dysfunction drug Viagra online in hopes of thwarting counterfeit Web-only pharmacies, holding off legitimate competitors, and boosting profits. The pharmaceutical industry will watch this closely because it could change how drugs are bought, paid for, and delivered through the many layers of the current and complicated system. Pfizer will market the drug through viagra.com, but CVS Caremark will handle the online processing and shipping.